[Acute kidney injury - status of biomarkers in perioperative and critically ill patients]

Anasthesiol Intensivmed Notfallmed Schmerzther. 2016 Nov;51(11-12):698-706. doi: 10.1055/s-0042-101442. Epub 2016 Nov 24.
[Article in German]

Abstract

Acute kidney injury (AKI) impairs short- and long-term prognosis of affected patients even in case of apparantly mild course and 'full' recovery as measured by follow-up serum creatinine concentrations. Late or none intervention worsens prognosis. However, there are modifiable factors potentially contributing to preserved long-term renal function. Effective treatment is multifactorial and includes identification and reversal of AKI etiology and generation of a (micro)environment for optimal renal recovery. Available treatment options for AKI in perioperative and critically ill patients will be discussed in the setting of novel kidney biomarkers.

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / blood*
  • Acute Kidney Injury / diagnosis
  • Biomarkers / blood
  • Creatinine / blood*
  • Critical Illness
  • Cystatin C / blood*
  • Evidence-Based Medicine
  • Humans
  • Insulin-Like Growth Factor Binding Proteins / blood
  • Intraoperative Complications / blood*
  • Intraoperative Complications / diagnosis
  • Lipocalin-2 / blood*
  • Monitoring, Intraoperative / methods
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tissue Inhibitor of Metalloproteinase-2 / blood*

Substances

  • Biomarkers
  • Cystatin C
  • Insulin-Like Growth Factor Binding Proteins
  • LCN2 protein, human
  • Lipocalin-2
  • insulin-like growth factor binding protein-related protein 1
  • Tissue Inhibitor of Metalloproteinase-2
  • Creatinine